Viewing nowOlmesartan Medoxomil 10 mg Tablet
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
L&C Bio Co., Ltd.

MFDS item code 201904736 · Approved 2019.07.15 · Insurance code 060500640
Treatment of essential hypertension
Essential hypertension refers to a condition where blood pressure is persistently high without a specific cause. This medication lowers blood pressure, reducing the burden on the heart and blood vessels. With consistent use, it may also reduce the risk of complications such as stroke or heart disease. Additionally, it helps to maintain stable blood pressure, reducing discomfort in daily life. It is used in the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg per day. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at about 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this medicine to elderly patients aged 65 years or older. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose in patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 200mg per day. Use is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.
Safety and efficacy in children have not been established.
This medication can cause severe harm or death to the fetus and newborn if taken in the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used in patients with allergies to this drug or its components, pregnant or breastfeeding women, patients undergoing kidney dialysis, patients with severe liver dysfunction, patients with biliary obstruction, patients with lactose intolerance, particular diabetic patients, and others as indicated. Patients with reduced blood volume or sodium may experience symptoms of hypotension, so their condition should be closely monitored before administration, and appropriate measures should be taken if necessary. In patients with severe heart failure who are dependent on kidney function, changes in kidney function may occur, so caution is needed. Patients with poor kidney function or kidney transplant recipients should frequently check their kidney function and electrolyte status through blood tests, and it's advisable not to use it in patients with severe kidney impairment. In patients with certain renovascular hypertension, worsening of kidney function may occur, so caution is required. This medication may increase potassium levels in the body, so patients with heart or kidney diseases should regularly check their potassium levels. Patients with aortic or mitral valve stenosis and obstructive heart disease should be cautious as symptoms may worsen due to the blood pressure-lowering effect of this medication. It may be ineffective in patients with specific hormonal abnormalities. This medication can lower blood pressure, potentially causing dizziness, so care should be taken when performing potentially dangerous activities like operating machinery or driving. This medication may produce a somewhat lesser blood pressure-lowering effect in Black patients compared to patients of other races. Side effects of this medication are usually mild and transient, potentially including dizziness, headache, dyspepsia, muscle pain, and rash. Facial swelling or angioedema can occur infrequently, so if symptoms appear, immediate consultation with healthcare professionals is advised. Liver function abnormalities or changes in blood test results have been reported uncommonly, so liver function tests may be necessary. If symptoms of weight loss and chronic diarrhea occur during long-term use of this medication, it should be discontinued and a physician consulted. When taking this medication with other blood pressure medications, potassium-sparing diuretics, or potassium supplements, caution is needed as it may increase blood potassium levels. In combination with lithium preparations, there is a risk of lithium toxicity, so concurrent use is not recommended. When used with non-steroidal anti-inflammatory drugs, there is a risk of worsening kidney function, so fluid intake and kidney function monitoring are necessary. Pregnant women should avoid taking this medication due to the risk of severe fetal harm, and it should be discontinued immediately if pregnancy is confirmed. Breastfeeding women should either discontinue breastfeeding or this medication as it may be excreted in breast milk. Safety in children has not been established, so caution is advised in use. Elderly patients may require dosage adjustments and monitoring as drug concentrations may be higher in their bodies. In case of overdose, symptoms such as hypotension and palpitations may occur, and if symptoms arise, immediate consultation with healthcare professionals is necessary. There have been no major risks reported regarding carcinogenicity or genotoxicity; however, regular check-ups are necessary to confirm safety, even with long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be kept between 1°C and 25°C at room temperature. This helps maintain the drug's effectiveness and safety over time.
White, round, film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 10mg
Tablet · Prescription medication
L&C Bio Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.